CSIMarket
 


Sutro Biopharma Inc   (STRO)
Other Ticker:  
 
 

STRO's EPS Net Growth by Quarter and Year

Sutro Biopharma Inc 's EPS Net results by quarter and year




STRO EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.55 -0.82 -1.49
III Quarter September -0.81 -0.37 -0.67 0.45
II Quarter June -0.64 -0.55 -0.13 0.94
I Quarter March -0.85 -0.84 -0.66 -0.84
FY   -2.30 -2.31 -2.28 -0.94



STRO EPS Net third quarter 2023 Y/Y Growth Comment
Sutro Biopharma Inc in the third quarter 2023 recorded EPS net loss of $ -0.81 .

According to the results reported in the third quarter 2023, Sutro Biopharma Inc achieved the best EPS Net growth in Biotechnology & Pharmaceuticals industry. While Sutro Biopharma Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2023.




STRO EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Sutro Biopharma Inc 's third quarter 2023 EPS Net $ -0.81 STRO's Income Statement
Sutro Biopharma Inc 's third quarter 2022 EPS Net $ -0.37 Quarterly STRO's Income Statement
New: More STRO's historic EPS Net Growth >>


STRO EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -52.13 %
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Sutro Biopharma Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


STRO's III. Quarter Q/Q EPS Net Comment
Current EPS net loss of -0.81 by Sutro Biopharma Inc look even less good considering the EPS net loss -0.64 in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Sutro Biopharma Inc achieved highest sequential EPS Net growth. While Sutro Biopharma Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


STRO's III. Quarter Q/Q EPS Net Comment
III. Quarter 2023 accomplishment of -0.81 by Sutro Biopharma Inc look even worse compare to the -0.64 a quarter before.

Within Biotechnology & Pharmaceuticals industry Sutro Biopharma Inc achieved highest sequential EPS Net growth. While Sutro Biopharma Inc 's EPS Net growth quarter on quarter, overall rank is .


Sutro Biopharma Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS Net 12 Months Ending $ -2.85 $ -2.41 $ -2.32 $ -2.31 $ -2.58
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Sutro Biopharma Inc ' has realized cumulative trailing twelve months EPS net loss of $ -3 in the Sep 30 2023 period.
The situation is detiriorating as the cumulative EPS net loss is becoming larger from $ -2.41 in TTM ending quarter Jun 30 2023 and $ -2.8836111749897 for the twelve months ending in the quarter a year ago.

Sutro Biopharma Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Sutro Biopharma Inc ' has realized cumulative trailing twelve months EPS net loss of $ -3 in the Sep 30 2023 period.
The results are detiriorating as the cumulative EPS net loss is inflating from $ -2.41 in the twelve months ending a quarter before and $ -2.8836111749897 from the TTM period ending Sep 30 2022 Audrey Jackson told.

Sutro Biopharma Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Pharmaceuticals Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
STRO's EPS Net Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for STRO's Competitors
EPS Net Growth for Sutro Biopharma Inc 's Suppliers
EPS Net Growth for STRO's Customers

You may also want to know
STRO's Annual Growth Rates STRO's Profitability Ratios STRO's Asset Turnover Ratio STRO's Dividend Growth
STRO's Roe STRO's Valuation Ratios STRO's Financial Strength Ratios STRO's Dividend Payout Ratio
STRO's Roa STRO's Inventory Turnover Ratio STRO's Growth Rates STRO's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2023
Amphastar Pharmaceuticals Inc 203.33%$ 203.333 
Alpha Pro Tech Ltd 200.00%$ 200.000 
Conduit Pharmaceuticals Inc 200.00%$ 200.000 
Boston Scientific Corporation183.33%$ 183.333 
Viemed Healthcare Inc 133.33%$ 133.333 
Davita Inc 131.86%$ 131.858 
Cadre Holdings Inc 123.08%$ 123.077 
Lantheus Holdings Inc 118.60%$ 118.605 
Orasure Technologies Inc114.29%$ 114.286 
Electromed Inc 100.00%$ 100.000 
Encompass Health Corporation86.67%$ 86.667 
Molecular Templates inc 86.36%$ 86.364 
Select Medical Holdings Corp80.95%$ 80.952 
Align Technology inc 69.89%$ 69.892 
Integer Holdings Corporation68.75%$ 68.750 
Docgo Inc 66.67%$ 66.667 
Merit Medical Systems Inc62.96%$ 62.963 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com